» Articles » PMID: 40018087

Pancreatic β-cell Function is Higher in Morning Versus Intermediate Chronotypes With Obesity

Overview
Journal Obes Sci Pract
Date 2025 Feb 28
PMID 40018087
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: People with later chronotypes are at greater T2D risk, yet it is unknown if β-cell function differs among chronotypes. Thus we, assessed β-cell function in morning (MORN) and intermediate (INT) chronotypes with obesity.

Methods: Adults ( = 41, 9M, 55 ± 1.7 y, 36.8 ± 1.0 kg/m) were grouped as MORN or INT per the Morningness-Eveningness Questionnaire. Glucose, insulin, C-peptide, GIP, and GLP-1(active) were collected every 30 min during a 120 min 75g-OGTT. Insulin secretion rates (ISR) were calculated (regularized deconvolution) to assess early (total area under the curve; tAUC) and total-phase (tAUC) glucose-stimulated insulin secretion (GSIS:ISR/Glucose). Skeletal muscle (glucose infusion rate/steady-state insulin) insulin sensitivity and hepatic (HOMA-IR) as well as adipose (Adipose-IR) insulin resistance were assessed during a 120 min euglycemic hyperinsulinemic clamp (40mU/m/min, 90 mg/dL). β-cell function (disposition index (DI): GSIS adjusted insulin sensitivity) was determined. Body composition (DXA) and fitness (VOmax) were also measured.

Results: Age, body composition and VOmax were similar between groups, but INT had reduced muscle insulin sensitivity and higher hepatic and adipose IR ( < 0.05). INT had higher C-peptide tAUC ( = 0.04) and lower hepatic DI (tAUC  = 0.05 and tAUC  = 0.07, respectively). Early phase hepatic DI correlated with GLP-1 tAUC ( = 0.35,  < 0.02) and tAUC ( = -0.40,  = 0.04).

Conclusions: β-cell function was higher in MORN versus INT chronotypes. Further work is warranted to discern how chronotype impacts insulin secretion.

Trial Registration: NCT03355469.

References
1.
Cole J, Motivala S, Buysse D, Oxman M, Levin M, Irwin M . Validation of a 3-factor scoring model for the Pittsburgh sleep quality index in older adults. Sleep. 2006; 29(1):112-6. DOI: 10.1093/sleep/29.1.112. View

2.
Remchak M, Heiston E, Ballantyne A, Dotson B, Stewart N, Spaeth A . Insulin Sensitivity and Metabolic Flexibility Parallel Plasma TCA Levels in Early Chronotype With Metabolic Syndrome. J Clin Endocrinol Metab. 2022; 107(8):e3487-e3496. PMC: 9282268. DOI: 10.1210/clinem/dgac233. View

3.
Mason I, Qian J, Adler G, Scheer F . Impact of circadian disruption on glucose metabolism: implications for type 2 diabetes. Diabetologia. 2020; 63(3):462-472. PMC: 7002226. DOI: 10.1007/s00125-019-05059-6. View

4.
Van Cauter E, Polonsky K, Scheen A . Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev. 1997; 18(5):716-38. DOI: 10.1210/edrv.18.5.0317. View

5.
Jensen M, Nielsen S . Insulin dose response analysis of free fatty acid kinetics. Metabolism. 2006; 56(1):68-76. DOI: 10.1016/j.metabol.2006.08.022. View